Nadine Rouphael, MD

Dr. Rouphael is a physician scientist with expertise in all phases of clinical trials for vaccine, diagnostic, device, antimicrobial resistance, PK/PD, epidemiology, human challenge model and translational immunology studies. Over the past 12 years, she has served as the national chair/co-chair as well as lead PI/site PI of 50 protocols and as a co-investigator for more than 130 trials addressing a variety of infectious diseases priorities in diverse populations. She serves as the Executive Director of the Hope Clinic, the clinical arm of the Emory Vaccine Center and as the Emory VTEU PI since 2018. She is also the PI of the Clinical Core for the NIAID-funded Emory Human Immunology Project Consortium (HIPC) where she serves as the national chair for the HIPC clinical subcommittee and as a member of the HIPC scientific steering committee. She serves as a co-investigator on the Emory-CDC Clinical Trials Unit. She has mentored numerous students, residents, fellows and junior faculty and is committed to training the next generation of investigators by serving as Associate Director for the Emory T32 Vaccinology grant and as the multiple PI for the Emory Stimulating Access to Research in Residency (StARR) (R38).